Catalyze Preclinical Services Program
The Preclinical Services Program expands the support available to innovators with a heart, lung, blood, or sleep to include preclinical development activities from end-stage proof-of-concept through preclinical development and US regulatory submissions. Preclinical services are tailored to the development needs of each product. Applicants can request specific services required to advance their technology to the clinic or regulatory submission. Once a project is selected for support, the level of support and services provided are negotiated between the Principal Investigator and NHLBI.
{iframe}https://my.visme.co/view/dmggv8ng-catalyze-quarterly-winter-2023{/iframe}